Among the companies whose shares are expected to see active trade in Monday's session are TXU Corp. (TXU), Nordstrom Inc. (JWN), and XM Satellite Radio Holdings Inc. (XMSR)

Applied Signal Technology (APSG) is expected to report first-quarter earnings of 10 cents a share, according to a survey of analysts by Thomson Financial.

Brocade Communications Systems Inc. (BRCD) is expected to post earnings of 13 cents a share for the first quarter.

• Get more hot tips in FOXBusiness.com's Investing Center.

Ceradyne Inc. (CRDN) is expected to report fourth-quarter earnings of $1.18 a share.

DTE Energy Co. (DTE) is expected to post earnings of 42 cents a share for the fourth quarter.

GlobalSantaFe Corp. (GSF) is expected to report fourth-quarter earnings of $1.21 a share.

Guitar Center Inc. (GTRC) is expected to post earnings of $1.07 a share for the fourth quarter.

Marvell Technology Group Ltd. (MRVL) is expected to report second-quarter earnings of 22 cents a share.

Nordstrom Inc. (JWN) is expected to post earnings of 90 cents a share for the fourth quarter.

Warnaco Group Inc. (WRNC) is expected to report fourth-quarter earnings of 49 cents a share.

XM Satellite (XMSR) is expected to post a loss of 71 cents a share for the fourth quarter.

After Friday's closing bell, a judge in Delaware once again delayed a shareholder vote on the proposed merger of pharmacy benefits manager Caremark Rx Inc. (CMX) and retail pharmacy CVS Corp. (CVS) until the PBM provides its shareholders with additional information about the deal, but stopped short of canceling the vote altogether.

Also late Friday, KB Home (KBH) said it has been informed by the Department of Justice that it is not a target of the agency's stock option grant investigation. "The Department of Justice is also looking into these practices but has informed KB Home that it is not a target of this investigation," the home builder said in a statement.

In a regulatory filing last month, the Los Angeles-based company said the Securities and Exchange Commission was formally investigating its stock-option granting practices. Earlier Friday, a published report said KB Home was under criminal investigation by the U.S. Attorney's Office in Los Angeles over so-called options backdating that triggered the resignation of the home builder's longtime chief executive.

Watch list

AMB Property Corp. (AMB) late Friday said it plans to sell 8 million shares of its common stock in a registered offering. The San Francisco-based real estate developer also said it plans to grant underwriters an option to issue up to 1.2 million additional shares to cover over-allotments, if any.

DaimlerChrysler AG (DCX) shares rose following reports the German-American car maker is in talks with at least four private equity groups over the sale of its Chrysler division. Apollo Management, Blackstone, Carlyle and Cerberus Capital Management were contacted by DaimlerChrysler last week, according to the Financial Times.

Dominion Homes Inc. (DHOM) reported a fourth-quarter net loss of $17 million, or $2.09 a share. In the same quarter last year, the Dublin, Ohio-based homebuilder posted a net profit of $991,000, or 12 cents a share. Revenue dropped to $54.2 million from $111.5 million. The company delivered 284 homes and sold 131 in the three months ended Dec. 31, compared with 571 homes delivered and 230 sold in the comparable period last year.

Gilead Sciences Inc. (GILD) said a Phase II clinical trial of its investigational HIV integrase inhibitor GS 9137 met its primary endpoint. Integrase inhibitors are an investigational class of antiretrovirals that interfere with HIV replication by blocking the ability of the virus to integrate into the genetic material of human cells, Foster City. Calif.-based Gilead said. GS 9137 was licensed by Gilead from Japan Tobacco Inc. in March of 2005.

Hawaiian Electric Industries Inc. (HE) reported fourth-quarter net earnings of $16.1 million, or 20 cents a share, down from $37.5 million, or 46 cents a share, during the year-ago period. The Honolulu-based utility and banking company posted total revenue of $607.1 million vs. $624.8 million.

Ipsco Inc. (IPS) said it has approved a new shareholder rights plan. The current plan expires at the annual meeting of shareholders in April, the Lisle, Ill.-based steel pipe and plate maker said. "This shareholder rights plan is intended to help protect our shareholders and is designed to help ensure they will receive fair and equal treatment in the event of any takeover," said Ipsco Chairman Burton Joyce in a statement.

Keane Inc. (KEA) said it has received an inquiry from the Securities and Exchange Commission requesting documents related to the company's stock option grants and practices. The Boston-based business process and IT services company said it plans to cooperate with the SEC.

Lam Research Corp. (LRCX) said it has approved the buyback of $750 million of its common shares. Fremont, Calif.-based Lam Research is a chip-equipment maker.

Lowe's Cos. (LOW) said the slowdown in the nation's housing industry, coupled with high hurdles stemming from last year's hurricane-recovery efforts, were key factors behind an 11.5 percent drop in its fourth-quarter income.

National Medical Health Card Systems Inc. (NMHC) reported fiscal first-quarter net earnings of $1.41 million, down from $2.87 million in the same period last year. Net loss available to common stockholders for three months ended Sept. 30, 2006, was $121,000, or 2 cents a share, compared with net income available to common stockholders of $1.34 million, or 24 cents a share, in the comparable period a year ago.

Revenue fell 12.1 percent to $188.7 million from $214.7 million.

Third Point LLC said it's proposing to nominate six directors to the board of Pogo Producing Co. (PPP) . Entities advised by Third Point currently hold 4.615 million shares of Pogo common stock, or roughly 7.9 percent of its shares.

Shire Plc (SHPGY) (SHP) and New River Pharmaceuticals Inc. (NRPH) said the Food and Drug Administration has granted marketing approval for Vyvanse for the treatment of attention deficit hyperactivity disorder. The FDA has proposed that Vyvanse be classified as a Schedule II controlled substance.

The proposal was accepted by the Drug Enforcement Administration, the companies said. A final scheduling decision is expected from the DEA following a 30-day period for public comment. Pending final scheduling designation, the product launch is expected in the second quarter.

Vyvanse, a prodrug that is therapeutically inactive until metabolized in the body, will be available in three dosage strengths: 30 mg, 50 mg and 70 mg, the companies said. Earlier this week, Shire agreed to acquire New River for $64 a share in cash, or about $2.6 billion.

Private-equity firms Kohlberg Kravis Roberts & Co. and Texas Pacific Group are preparing a bid for TXU Corp. (TXU) , the Wall Street Journal reported on its Web site. The firms are expected to offer around $70 a share for the Dallas-based utility, the Journal reported, citing one person familiar with the matter. Other firms may also join the bid, the report said.

United Parcel Service Inc. (UPS) , the world's largest package-delivery company, said it renegotiated a contract with Airbus to delay and possibly cancel an order for 10 freighter versions of the European plane maker's mammoth new jet, the last remaining order for the cargo carrier on the books at Airbus.

Copyright (c) 2006 MarketWatch, Inc.